Seven Bridges to provide scRNAseq data management for Pfizer

By The Science Advisory Board staff writers

February 24, 2021 -- Bioinformatics provider Seven Bridges has been selected by Pfizer to provide data management services for Pfizer's single-cell RNA sequencing (scRNAseq) data.

The Seven Bridges platform is a cloud-based environment for conducting bioinformatic analyses where teams can store, analyze, and interpret data.

Under the agreement, Seven Bridges will support Pfizer by centralizing and managing terabytes of raw and processed scRNAseq data. These data provide detailed analysis of gene expression in individual cells. But the totality of scRNAseq data can carry a very large footprint. The Seven Bridges platform will provide a cost-effective, secure, end-to-end, scalable, durable, and reliable data storage and management solution for Pfizer.

Pfizer invests $120M in biotech innovation
Pfizer has invested $120 million in four clinical-stage biotech companies as part of its Pfizer Breakthrough Growth Initiative.
Javelin, Pfizer to develop organ-on-a-chip platform
Javelin Biotech has entered a three-year collaboration with Pfizer to design and build a platform to evaluate absorption, distribution, metabolism, and...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter